Literature DB >> 21830023

Rituximab in steroid refractory autoimmune hemolytic anemia.

Nitin Gupta1, Sanjeev Sharma, Tulika Seth, Pravas Mishra, Manoranjan Mahapatra, Suman Kumar, Rajan Kapoor, Narendra Agarwal.   

Abstract

Autoimmune hemolytic anemia is rare in children and infants and steroids are the corner stone of therapy. Management of the patients with steroid refractory/dependent disease is difficult .Rituximab is being used in the treatment of a variety of autoimmune diseases including Autoimmune hemolytic anemia (AIHA),especially in adults but there is scarce data regarding the use of this agent in pediatric AIHA patients.The authors report two cases of steroid refractory AIHA, who responded to rituximab with review the literature of its use in pediatrics.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21830023     DOI： 10.1007/s12098-011-0544-4

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


  9 in total

Review 1.  Childhood immune thrombocytopenic purpura: diagnosis and management.

Authors:  Victor Blanchette; Paula Bolton-Maggs
Journal:  Hematol Oncol Clin North Am       Date:  2010-02       Impact factor: 3.722

Review 2.  Treatment with rituximab in benign and malignant hematologic disorders in children.

Authors:  Lisa B Giulino; James B Bussel; Ellis J Neufeld
Journal:  J Pediatr       Date:  2007-04       Impact factor: 4.406

Review 3.  Autoimmune hemolytic anemia.

Authors:  B Agarwal
Journal:  Indian J Pediatr       Date:  1998 Sep-Oct       Impact factor: 1.967

4.  Treatment of childhood autoimmune haemolytic anaemia with rituximab.

Authors:  P Quartier; B Brethon; P Philippet; J Landman-Parker; F Le Deist; A Fischer
Journal:  Lancet       Date:  2001-11-03       Impact factor: 79.321

5.  Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias.

Authors:  Aarati Rao; Michael Kelly; Mark Musselman; Jagadeesh Ramadas; David Wilson; William Grossman; Shalini Shenoy
Journal:  Pediatr Blood Cancer       Date:  2008-04       Impact factor: 3.167

6.  Rituximab for the treatment of refractory autoimmune hemolytic anemia in children.

Authors:  Marco Zecca; Bruno Nobili; Ugo Ramenghi; Silverio Perrotta; Giovanni Amendola; Pasquale Rosito; Momcilo Jankovic; Paolo Pierani; Piero De Stefano; Mario Regazzi Bonora; Franco Locatelli
Journal:  Blood       Date:  2003-01-16       Impact factor: 22.113

7.  Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.

Authors:  M E Reff; K Carner; K S Chambers; P C Chinn; J E Leonard; R Raab; R A Newman; N Hanna; D R Anderson
Journal:  Blood       Date:  1994-01-15       Impact factor: 22.113

8.  Autoimmune hemolytic anemia.

Authors:  V Gupta; J Shukla; B D Bhatia
Journal:  Indian J Pediatr       Date:  2008-06-08       Impact factor: 1.967

9.  Rituximab-based immunosuppression for autoimmune haemolytic anaemia in infants.

Authors:  Johanna Svahn; Francesca Fioredda; Michaela Calvillo; Angelo C Molinari; Concetta Micalizzi; Laura Banov; Madalina Schmidt; Daniela Caprino; Doretta Marinelli; Domenico Gallisai; Carlo Dufour
Journal:  Br J Haematol       Date:  2009-02-04       Impact factor: 6.998
  9 in total
  4 in total

1.  B cell suppression in newborn following treatment of pregnant diffuse large B-cell lymphoma patient with rituximab containing regimen.

Authors:  Prakas Kumar Mandal; Tuphan Kanti Dolai; Basab Bagchi; Malay Kumar Ghosh; Sudipta Bose; Maitreyee Bhattacharyya
Journal:  Indian J Pediatr       Date:  2014-02-22       Impact factor: 1.967

2.  Successful treatment with rituximab of an infant with refractory autoimmune hemolytic anemia.

Authors:  Kunihiko Moriya; Tetsuro Matsuhashi; Masaei Onuma; Hidetaka Niizuma; Takeshi Rikiishi; Hiroshi Asada; Jun Suzuki; Yoji Sasahara; Shigeo Kure
Journal:  Int J Hematol       Date:  2013-05-24       Impact factor: 2.490

3.  Cold agglutinin-induced haemolysis in association with antinuclear antibody-negative SLE.

Authors:  Vinod K Chaubey; Lovely Chhabra
Journal:  BMJ Case Rep       Date:  2013-06-10

4.  Anti-CD20 Treatment of Autoimmune Hemolytic Anemia Refractory to Corticosteroids and Azathioprine: A Pediatric Case Report and Mini Review.

Authors:  Alexandros Makis; Zoi Kanta; Dimitrios Kalogeropoulos; Nikoloaos Chaliasos
Journal:  Case Rep Hematol       Date:  2018-08-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.